Standard Terms of Purchase and Supplier Integrity Guide/Code of Conduct: Enter Here.

Last Updated: 8 July 2020

Overview

GE Healthcare Life Sciences helps therapy innovators, researchers and healthcare providers accelerate how precision diagnostics and therapies are invented, made and used. Our products enable biological analysis, research, development and the manufacture of advanced therapies and vaccines. Our vision is a world where access to life-changing therapies transforms human health. We are 6500 employees serving customers and working with partners in dozens of countries around the world.

You may have seen the announcement that Danaher Corp intends to purchase the BioProcess, Cell and Gene Therapy, and Genomics & Cellular Research units of our business. The sale of GE Healthcare Life Sciences Biopharma business to Danaher is subject to customary closing conditions, including regulatory reviews and appropriate consultation processes, and it is expected to close in the first quarter of 2020.

Until the deal closes, we will continue to operate separately from Danaher. In preparation for the intended acquisition*, assets of the Biopharma business are undergoing a series of legal entity restructuring steps, including but not limited to, new legal entity formations, change in legal entity ownership and change in legal entity names. You will be receiving information if there is any change to our contracting or ‘bill to’ details.

* The sale of the GE Healthcare Life Sciences Biopharma business to Danaher is subject to customary closing conditions, including regulatory reviews and appropriate consultation processes, and is expected to close in the first quarter of 2020.

What this means to you, our suppliers

We have relationships with many suppliers and vendors who are being notified of the change in corporate structure. We want to be sure that business continues smoothly between us. This page is intended to help you navigate through the actions necessary to keep business moving as smoothly as possible. We will update this page as more information becomes available.

In some instances, the legal entity that the Biopharma business has contracted through (i.e., the GE contracting party) has or will be changing. In other cases, the legal entity that the Biopharma business has contracted through is not changing, but the ownership of the legal entity is changing, either through an internal restructuring and/or with the planned sale to Danaher at close.

What is not changing

We remain focused on being a great partner to you, our suppliers and vendors. Here is a list of what WILL NOT CHANGE as a result of transition steps:

  • Manufacturing processes.
  • In the case of indirect procurement and accounts payable, the Biopharma business will continue to leverage GE Healthcare systems .
  • If you are doing business with any other GE Healthcare business that is not BioProcess, Cell and Gene Therapy, or Genomics and Cellular Research, then you continue business as in the past.
  • ‘Bill to’ and ‘ship to’ in general do not change, except in limited cases. You will be notified of any change.

Changes you need to make

Look out for notices about changes in contracting party or invoicing details. Click here (updated 8.07.2020) to see the table which lists which legal entities are changing and when.

Any receipted orders or releases that are in the process of payment might require a re-issue of a purchase order. Please be on the lookout if a PO is reissued to you. Invoices addressed to the incorrect legal entity may be rejected and you may need to work with requestor to get details of the new PO to be able to reissue the invoices. You may be notified to update invoicing and bank account information to reflect the new legal entity where applicable.

Our IT Team has been working to ensure that our systems are ready for this change. We are taking steps to ensure there is no impact to Supply Chain, and that all supplier invoices are paid on time.

Contacts

iSupplier Portal Help Desk Support Lines

(Use option1 for iSupplier Portal)

Toll free U.S.

800-717-7892

Toll free Mexico

866-301-4661

Dial comm internal

8*320-7500

Direct dial globally

01 262-312-7500

Toll free China

10-800-120-0928

Toll free France

0800-904992

Toll free Italy

800-784468

Toll free UK

08-082346100

Toll free Finalnd

0-800-1-13057

Toll free India

1800-345-6716

SupplierConnectL1Support@ge.com

iSupplier portal - Purchase Orders & Forecast information link (Requires registration) Enter Here

If you have been requested by the business to register for a GE SSO in order to utilize our portals please click here to begin the process

Accounts Payable Contacts

If you need to check the status of an invoice you can do that through the following link: Click Here.

If you need to reach out to the Accounts Payable team with questions, please raise a ticket in Oracle Service Cloud tool: Click Here.

Frequently asked questions

The Transaction

Overall Announcement